Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Progenics Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Auris Medical to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference on Tuesday, July 12
-
InVivo Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Advaxis to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Inotek Pharmaceuticals to Present at Upcoming Investor Conferences
-
Spark Therapeutics Announces Participation in Conferences in July
-
Nicox to present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Nobilis to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Array BioPharma To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference
-
OncoMed Management to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Fibrocell to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Tonix Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Ekso Bionics™ to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Lexicon To Present At The Cantor Fitzgerald Healthcare Conference
-
Ignyta to Present at 2016 Cantor Fitzgerald Healthcare Conference
-
Celldex Therapeutics to Participate in the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Unusual 11 Mid-Day Movers 7/7: (LEDS) (USEG) (AVG) Higher; (GPL) (SEV) (FLSR) Lower
-
M III Acquisition (MIII) Prices 15M Units IPO for Proceeds of $150M
-
M III Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
-
CymaBay Announces Participation at Cantor Fitzgerald Healthcare Conference on July 12th in New York
-
Celsion Corporation to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Cantor Fitzgerald Starts Cerus (CERS) at Buy
-
Omeros to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
AGTC to Present at the Cantor Fitzgerald Second Annual Healthcare Conference on July 13, 2016
-
Syndax Pharmaceuticals to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
NewLink Genetics to Participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Egalet to Present at Cantor Fitzgerald Healthcare Conference
-
Great Panther Silver increases previously announced bought deal financing to US$26 million
-
Vericel to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Collegium to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Prothena to Participate in Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Theravance Biopharma to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Nivalis Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Oncobiologics, Inc. to Present at the 2016 Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Prothena to Participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Great Panther Silver (GPL) Reports $20M in Bought Deal Financing
-
Great Panther Silver arranges US$20 million bought deal financing
-
UPDATE: Cantor Fitzgerald Starts Tobira Therapeutics (TBRA) at Buy
-
UPDATE: Cantor Fitzgerald Initiates Coverage on Intercept (ICPT) with 'Sell' Rating; Analyst Pans Opportunity in NASH
-
Alimera Sciences to Present at the Cantor Fitzgerald Conference
-
AMSURG Corp. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
SCYNEXIS, Inc. to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Innocoll Holdings plc to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Flex Pharma to Present at the Cantor Fitzgerald Healthcare Conference
-
Corvus Pharmaceuticals to Present at Cantor Fitzgerald’s Second Annual Healthcare Conference on July 12
-
Relypsa to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
The Female Health Company to Present at the 2nd Annual Cantor Fitzgerald Healthcare Conference on Wednesday, July 13, 2016
-
Amarin to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Genocea to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Ocular Therapeutix™ to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
